key: cord-0813390-2vd0ssfm
authors: Alturk, Ahmad; Bara, Albaraa; Darwish, Bassam
title: Post-intubation tracheal stenosis after severe COVID-19 infection: A report of two cases
date: 2021-06-09
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2021.102468
sha: b74087f92fbc0540e2ade7a53b922f7b0f4bf47f
doc_id: 813390
cord_uid: 2vd0ssfm

INTRODUCTION AND IMPORTANCE: Coronavirus disease 2019 (COVID-19) is a pandemic disease that spread rapidly throughout the world and became a major public health concern. Approximately 5–12% of COVID-19 patients require admission to the intensive-care unit (ICU), where they often require oxygen therapy and prolonged intubation. Post-intubation laryngotracheal stenosis (PILS) is a complication that occurs in 10–22% of non-COVID-19 patients after prolonged intubation, while the rate of COVID-19 related PILS remains unknown. Additionally, there is still no consensus in the literature regarding the management modalities for PILS following COVID-19. CASE PRESENTATION: Here we report two cases of tracheal stenosis after prolonged intubation due to severe COVID-19 infection. The first patient was admitted to the ICU and intubated for 21 days; 3 months after discharge, he developed a 3 cm long tracheal stenosis that narrowed 70% of the lumen. The second patient was intubated for 2 months and, 4 months after discharge, developed a 2.5 cm long tracheal stenosis that narrowed 80% of the lumen. CLINICAL DISCUSSION: In both cases, the diagnosis was confirmed by CT scan and Rigid bronchoscopy; then, they were managed successfully with tracheal resection and reconstruction by end-to-end anastomosis. CONCLUSION: In conclusion, we would like to highlight the importance of suspecting PILS in recovered COVID-19 patients re-presenting with breathing difficulties following weaning from mechanical ventilation; therefore, careful follow-up in such patients is required. Moreover, we would like to point out that the management of tracheal stenosis after COVID-19 appears to be similar to that of tracheal stenosis in general.

Here we report two cases of tracheal stenosis after prolonged intubation due to severe COVID-19 infection. The first patient was admitted to the ICU and intubated for 21 days; 3 months after discharge, he developed a 3 cm long tracheal stenosis that narrowed 70% of the lumen. The second patient was intubated for 2 months and, 4 months after discharge, developed a 2.5 cm long tracheal stenosis that narrowed 80% of the lumen.

In both cases, the diagnosis was confirmed by CT scan and Rigid bronchoscopy; then, they were managed successfully with tracheal resection and reconstruction by end-to-end anastomosis.

In conclusion, we would like to highlight the importance of suspecting PILS in recovered COVID-19 patients re-presenting with breathing difficulties following weaning from mechanical ventilation; therefore, careful follow-up in such patients is required. Moreover, we would like to point out that the management of tracheal stenosis after COVID-19 appears to be similar to that of tracheal stenosis in general.

Keywords: COVID-19; PILS; stenosis; resection; Case report.

Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by a coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread rapidly across every country and has become a major public health concern [1]. Most COVID-19 patients present with minor symptoms like fever, cough, fatigue, headache, new loss of taste or smell, sore throat, nausea, and gastrointestinal symptoms [2] . In a low number of patients, the disease may take a severe form with serious complications, including interstitial pneumonia, acute respiratory failure, acute respiratory distress syndrome (ARDS), multiple organ failure, and death [3] .

Only 5-12% of COVID-19 patients require admission to the intensive-care unit (ICU); such patients often require prolonged mechanical ventilation with high positive end-expiratory pressure (PEEP) through an endotracheal tube [2] .

While tracheal intubation is a life-saving procedure, it may cause mucosal damage and tracheal wall necrosis, which leads to laryngotracheal stenosis [4] . The rate of post-intubation laryngotracheal stenosis (PILS) in non-COVID-19 patients is 10-22% [3] . Although the rate of COVID-19 related PILS remains unknown, it is thought that this complication is more common in COVID-19 patients after prolonged tracheal intubation [3] . On top of that, the choice of the modality of management of these patients is still undetermined.

In this paper, we report two cases of patients with post-intubation tracheal stenosis diagnosed during their recovery phase of COVID-19 and treated by surgical resection and reconstruction by end-to-end anastomosis. This work has been reported in line with the SCARE criteria [5] .

A 35-year-old man presented to our hospital complaining of dyspnea with stridor that started a month before and exacerbated during the last week. The patient was a non-smoker and had no significant surgical or family history. 4 months before, he was admitted to the intensive care unit (ICU) and intubated for 21 days due to acute respiratory failure that occurred as a complication of COVID-19. On admission, his peripheral oxygen saturation (SpO 2 ) was 96% on room air. CT scan showed signs of tracheal stenosis. He underwent 3 attempts of tracheal dilatation without a satisfactory outcome. Rigid bronchoscopy revealed a 3 cm long tracheal stenosis that narrowed 70% of the lumen; the stenosis was 5 mm below the cricoid cartilage. The stenosis was managed successfully with tracheal resection and reconstruction. The postoperative period was uneventful, and the patient was reassessed after 2 months: his general condition was good without complaints, and bronchoscopy revealed a non-narrowing anastomotic line.

J o u r n a l P r e -p r o o f A 62-year-old man presented to our hospital complaining of dyspnea and wheezing that started 2 months before and exacerbated during the last 10 days. The patient was a moderate smoker with a history of poorly controlled hypertension diagnosed 23 years ago. 6 months before, he was diagnosed with COVID-19 and admitted to the ICU due to the rapid deterioration of his respiratory condition. He was put on a mechanical ventilator for 2 months. On admission, his SpO 2 was 95% on room air. CT scan showed signs of tracheal stenosis (Figure 1) . Rigid bronchoscopy revealed a 2.5 cm long tracheal stenosis that narrowed 80% of the lumen; the stenosis was 2 cm below the cricoid cartilage. We dilated the stenosis as a temporary solution, then we performed tracheal resection and reconstruction. The patient made a full recovery, and the postoperative period was uneventful.

PILS is a rare condition with an estimated incidence of 4.9 cases per million per year in the general population [6] . PILS becomes symptomatic (1-2% of cases) when the stenosis includes >60% of the tracheal lumen. Previous reports showed that the time of onset of PILS varied from 28 days to 6 months after extubation [3] . The most common cause of PILS is iatrogenic [7] , specifically in prolonged intubations, endotracheal tube cuff hyperinflation, and the usage of large tubes. Other risk factors include peritube infections, advanced age, female and estrogen effect, smoking, obesity, and diabetes.

There are still no data about the occurrence of PILS in recovered COVID-19 patients. However, it is thought that those patients could be at increased risk of developing PILS; perhaps most notably due to their hyperinflammatory state, which causes altered fibrosis, but also because those patients are subjected to prolonged intubations and usually already have comorbidities, such as diabetes and hypertension [7] .

Early tracheostomy is recommended for patients who require prolonged tracheal intubation [8] , which is the case of most COVID-19 patients admitted to the ICU [2] . However, the global trend for COVID-19 patients admitted to ICU is to postpone tracheostomy until the patient no longer needs mechanical ventilation and is cleared of the virus; this delay is mainly due to the high risk of cross-infection of healthcare professionals [6] . Early reports state that COVID-19 patients remained intubated from one to two weeks or longer [3] . In our case, one patient underwent 3 weeks and the other 8 weeks of mechanical ventilation.

Although Mr. Francesco Mattioli et al. [9] suggested managing tracheal stenosis that occurs after COVID-19 endoscopically with balloon dilation and local corticosteroid injection, which maintains an adequate airway that enables breathing for an acceptable period, he mentioned that this procedure could be temporary, and other procedures may be needed later; probably tracheal resection and reconstruction, as we did to our patients, who were both suitable for surgery. In another paper [7] , Mr. Carmine Fernando Gervasio et al. reported managing two cases of tracheal stenosis following COVID-19: one with intravenous corticosteroids, while the other with tracheal resection. Nevertheless, we concur with Mr. Mattioli that dilation should be performed in patients with "thin and young" stenosis or when surgery is not feasible because the patient has comorbidities, which is the case of the majority of COVID-19 patients that needed prolonged intubation. Consequently, dilation and other procedures that sustain the airway patency, such as tracheal stent placement, are temporary procedures performed when the patient cannot withstand surgery or when the tracheal stenosis is not suitable for resection and reconstruction by end-to-end anastomosis (in the case of long stenosis or tracheal mucosa infection).

As an approach for tracheal stenosis, the location, length, and severity of the stenosis are essential factors in the management plan. If the J o u r n a l P r e -p r o o f stenosis is suitable for resection and reconstruction by end-to-end anastomosis and the patient can withstand the operation, surgery is recommended; otherwise, other therapeutic procedures are performed. Thus, the management strategies for tracheal stenosis after COVID-19 are similar to those for tracheal stenosis in general.

we presented two cases of post-intubation tracheal stenosis that occurred after COVID-19. It should highlight the importance of suspecting tracheal stenosis in recovered COVID-19 patients representing with breathing difficulties following weaning from mechanical ventilation; therefore, careful follow-up in such patients is required. Moreover, we would like to point out that the management of tracheal stenosis after COVID-19 appears to be similar to that of tracheal stenosis in general.

Written informed consent was obtained from our two patients for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

All of the authors declared that they have no conflict of interest.

J o u r n a l P r e -p r o o f Provenance and peer review: Not commissioned, externally peer-reviewed.

None.

None.

None.

AB: reviewed the literature, wrote the abstract, and the introduction.

AA: reviewed the literature, wrote the case presentation, and the discussion BD: lead the surgical team, checked the spelling and grammar, revised the manuscript and helped in writing the discussion.

-Tracheal stenosis (TS) is a rare complication that follows prolonged intubation. -Prolonged intubation causes tracheal wall damage, which leads to TS. -Suspect TS in recovered ICU-admitted COVID-19 patient re-presenting with dyspnea. -Stenosis length, severity, and location are essential in the management plan. -Consider non-surgical procedures in patients with "thin and young" stenoses.

Excess all-cause mortality during the COVID-19 pandemic in Europe -preliminary pooled estimates from the EuroMOMO network

Long-term intubation and high rate of tracheostomy in COVID-19 patients might determine an unprecedented increase of airway stenoses: a call to action from the European Laryngological Society

Two Cases of Post-intubation Laryngotracheal Stenosis Occurring after Severe COVID-19, Internal medicine

An Overview of Tracheal Stenosis Research Trends and Hot Topics

The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines

Estimating the population incidence of adult post-intubation laryngotracheal stenosis

Tracheal Stenosis After Tracheostomy for Mechanical Ventilation in COVID-19 Pneumonia -A Report of 2 Cases from Northern Italy

Early vs. late tracheostomy for the ICU patients: Experience in a referral hospital

Post-intubation tracheal stenosis in COVID-19 patients, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -Head and Neck Surgery

J o u r n a l P r e -p r o o f

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.All the authors declare that they have no conflicts of interest.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.There was no funding.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.No ethical approval was needed.

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. ⁷

Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Written informed consent was obtained from our two patients for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors.AB: reviewed the literature, wrote the abstract, and the introduction. AA: reviewed the literature, wrote the case presentation, and the discussion BD; led the surgical team, checked the spelling and grammar, revised the manuscript and helped in writing the discussion.

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.